Novel Opioid Receptor Drug Cuts IPF Cough

(MedPage Today) — The novel opioid agonist/antagonist nalbuphine offered relief from chronic cough associated with idiopathic pulmonary fibrosis (IPF), the phase IIb CORAL trial showed.
Nalbuphine extended release (ER) reduced objective cough…